Corcept Therapeutics
CORT
#2078
Rank
S$11.75 B
Marketcap
S$111.58
Share price
1.71%
Change (1 day)
40.29%
Change (1 year)

Corcept Therapeutics (CORT) - Cash on Hand

Cash on Hand as of September 2025 : S$0.54 Billion

According to Corcept Therapeutics 's latest financial reports the company has S$0.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Corcept Therapeutics - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31S$0.52 B7.14%
2023-12-31S$0.48 B-15.97%
2022-12-31S$0.57 B91.5%
2021-12-31S$0.30 B-48.17%
2020-12-31S$0.58 B56.7%
2019-12-31S$0.37 B31.71%
2018-12-31S$0.28 B137.98%
2017-12-31S$0.11 B59.13%
2016-12-31S$74.58 M30.41%
2015-12-31S$57.19 M78.52%
2014-12-31S$32.03 M-53.92%
2013-12-31S$69.52 M-38.89%
2012-12-31S$0.11 B121.64%
2011-12-31S$51.32 M62.13%
2010-12-31S$31.65 M-5.51%
2009-12-31S$33.5 M27.97%
2008-12-31S$26.18 M4.78%
2007-12-31S$24.98 M72.34%
2006-12-31S$14.49 M-70.05%
2005-12-31S$48.41 M-20.65%
2004-12-31S$61.01 M210.2%
2003-12-31S$19.66 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
S$24.05 B 4,301.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$21.38 B 3,813.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$12.63 B 2,212.87%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$12.84 B 2,250.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$19.41 B 3,453.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$23.60 B 4,219.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
S$0.11 B-78.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
S$0.33 B-38.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$1.91 B 250.46%๐Ÿ‡บ๐Ÿ‡ธ USA